Location History:
- Ichihara, JP (2020)
- Tokyo, JP (2015 - 2022)
- Taito-ku, JP (2022)
Company Filing History:
Years Active: 2015-2025
Title: Shinji Irie: Innovator in Cardiac and Cancer Research
Introduction
Shinji Irie, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the fields of cardiac health and cancer research. With a total of eight patents to his name, Irie's innovative work focuses on creating models and methods that enhance our understanding of heart diseases and cancer. His inventions hold the potential to revolutionize medical research and therapeutic approaches.
Latest Patents
Among his latest patents are two groundbreaking inventions. The first is the "Abnormal Cardiac Rhythm Myocardial Model and Method for Producing Same," which describes a three-dimensional tissue that contains cardiomyocytes and collagen. This model aims to improve the study of abnormal cardiac rhythms and their treatment. The second patent, "Method and Kit for Assessing Possibility of Cancerization," details a method for assessing the likelihood of cancer development by analyzing cell structures with vascular networks in the presence of biological specimens from subjects. This innovative approach provides a new avenue for early cancer detection.
Career Highlights
Shinji Irie's career has been marked by his affiliation with notable institutions such as Toppan Printing Co., Ltd. and Osaka University. His work at these organizations has allowed him to collaborate with other leading professionals and contribute to significant advancements in medical technology.
Collaborations
Irie has collaborated with esteemed colleagues including Shiro Kitano and Kei Tsukamoto. These partnerships have helped enhance his research and foster an environment of innovation, contributing to the development of new methodologies and applications in the medical field.
Conclusion
With his inventive spirit and dedication to advancing healthcare, Shinji Irie stands out as a prominent figure in medical innovation. His latest patents not only showcase his expertise but also his commitment to improving patient outcomes in cardiac and cancer care. As research continues to evolve, Irie's contributions will likely have a lasting impact on the future of medical science.